APA

Pauly D. F., Johnson B. D., Anderson R. D., Handberg E. M., Smith K. M., Cooper-DeHoff R. M., Sopko G., Sharaf B. M., Kelsey S. F., Merz C. N. B. & Pepine C. J. (20111123). In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the National Heart, Lung and Blood Institute Women's Ischemia Syndrome Evaluation (WISE). : American heart journal.

Chicago

Pauly Daniel F, Johnson B Delia, Anderson R David, Handberg Eileen M, Smith Karen M, Cooper-DeHoff Rhonda M, Sopko George, Sharaf Barry M, Kelsey Sheryl F, Merz C Noel Bairey and Pepine Carl J. 20111123. In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the National Heart, Lung and Blood Institute Women's Ischemia Syndrome Evaluation (WISE). : American heart journal.

Harvard

Pauly D. F., Johnson B. D., Anderson R. D., Handberg E. M., Smith K. M., Cooper-DeHoff R. M., Sopko G., Sharaf B. M., Kelsey S. F., Merz C. N. B. and Pepine C. J. (20111123). In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the National Heart, Lung and Blood Institute Women's Ischemia Syndrome Evaluation (WISE). : American heart journal.

MLA

Pauly Daniel F, Johnson B Delia, Anderson R David, Handberg Eileen M, Smith Karen M, Cooper-DeHoff Rhonda M, Sopko George, Sharaf Barry M, Kelsey Sheryl F, Merz C Noel Bairey and Pepine Carl J. In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the National Heart, Lung and Blood Institute Women's Ischemia Syndrome Evaluation (WISE). : American heart journal. 20111123.